These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 31969320)

  • 1. Industry funding of patient and health consumer organisations: systematic review with meta-analysis.
    Fabbri A; Parker L; Colombo C; Mosconi P; Barbara G; Frattaruolo MP; Lau E; Kroeger CM; Lunny C; Salzwedel DM; Mintzes B
    BMJ; 2020 Jan; 368():l6925. PubMed ID: 31969320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How do health consumer organisations in Australia manage pharmaceutical industry sponsorship? A cross-sectional study.
    Lau E; Fabbri A; Mintzes B
    Aust Health Rev; 2019 Aug; 43(4):474-480. PubMed ID: 30021681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Influence of Industry Sponsorship on the Research Agenda: A Scoping Review.
    Fabbri A; Lai A; Grundy Q; Bero LA
    Am J Public Health; 2018 Nov; 108(11):e9-e16. PubMed ID: 30252531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaceutical Industry Funding of Health Consumer Groups in Australia: A Cross-sectional Analysis.
    Fabbri A; Swandari S; Lau E; Vitry A; Mintzes B
    Int J Health Serv; 2019 Apr; 49(2):273-293. PubMed ID: 30646806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Financial relationships between patient and consumer representatives and the health industry: A systematic review.
    Khabsa J; Semaan A; El-Harakeh A; Khamis AM; Obeid S; Noureldine HA; Akl EA
    Health Expect; 2020 Apr; 23(2):483-495. PubMed ID: 31858662
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advertising and disclosure of funding on patient organisation websites: a cross-sectional survey.
    Ball DE; Tisocki K; Herxheimer A
    BMC Public Health; 2006 Aug; 6():201. PubMed ID: 16887025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluating solutions to sponsorship bias.
    Doucet M; Sismondo S
    J Med Ethics; 2008 Aug; 34(8):627-30. PubMed ID: 18667655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence and Disclosure of Potential Conflicts of Interest in Dermatology Patient Advocacy Organizations.
    Li DG; Singer S; Mostaghimi A
    JAMA Dermatol; 2019 Apr; 155(4):460-464. PubMed ID: 30698625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient Advocacy Organizations, Industry Funding, and Conflicts of Interest.
    Rose SL; Highland J; Karafa MT; Joffe S
    JAMA Intern Med; 2017 Mar; 177(3):344-350. PubMed ID: 28114624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient organizations' funding from pharmaceutical companies: is disclosure clear, complete and accessible to the public? An Italian survey.
    Colombo C; Mosconi P; Villani W; Garattini S
    PLoS One; 2012; 7(5):e34974. PubMed ID: 22590498
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there evidence for biased reporting of published adverse effects data in pharmaceutical industry-funded studies?
    Golder S; Loke YK
    Br J Clin Pharmacol; 2008 Dec; 66(6):767-73. PubMed ID: 18754841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reporting of conflicts of interest in meta-analyses of trials of pharmacological treatments.
    Roseman M; Milette K; Bero LA; Coyne JC; Lexchin J; Turner EH; Thombs BD
    JAMA; 2011 Mar; 305(10):1008-17. PubMed ID: 21386079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Industry Sponsorship With Outcomes of Nutrition Studies: A Systematic Review and Meta-analysis.
    Chartres N; Fabbri A; Bero LA
    JAMA Intern Med; 2016 Dec; 176(12):1769-1777. PubMed ID: 27802480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between pacifier use and breast-feeding, sudden infant death syndrome, infection and dental malocclusion.
    Callaghan A; Kendall G; Lock C; Mahony A; Payne J; Verrier L
    Int J Evid Based Healthc; 2005 Jul; 3(6):147-67. PubMed ID: 21631747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health advocacy organizations and the pharmaceutical industry: an analysis of disclosure practices.
    Rothman SM; Raveis VH; Friedman A; Rothman DJ
    Am J Public Health; 2011 Apr; 101(4):602-9. PubMed ID: 21233424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmaceutical industry sponsorship and research outcome and quality: systematic review.
    Lexchin J; Bero LA; Djulbegovic B; Clark O
    BMJ; 2003 May; 326(7400):1167-70. PubMed ID: 12775614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The association between ethnicity and delay in seeking medical care for chest pain: a systematic review.
    Wechkunanukul K; Grantham H; Damarell R; Clark RA
    JBI Database System Rev Implement Rep; 2016 Jul; 14(7):208-35. PubMed ID: 27532797
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of industry ties with outcomes of studies examining the effect of wholegrain foods on cardiovascular disease and mortality: systematic review and meta-analysis.
    Chartres N; Fabbri A; McDonald S; Turton J; Allman-Farinelli M; McKenzie J; Bero L
    BMJ Open; 2019 May; 9(5):e022912. PubMed ID: 31110080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Financial interests of patient organisations contributing to technology assessment at England's National Institute for Health and Care Excellence: policy review.
    Mandeville KL; Barker R; Packham A; Sowerby C; Yarrow K; Patrick H
    BMJ; 2019 Jan; 364():k5300. PubMed ID: 30651227
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.